This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Biomerieux Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the provision of scientific reagents and supplies, with a potential value of $200,184.68 and a completion date of September 30, 2024. The contract does not have a set-aside designation. Biomerieux Inc. is a leader in in vitro diagnostics, providing microbiological...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and services. The $144,184.32 contract is for a service maintenance agreement, with a performance period from May 2017 to May 2022. Biomerieux Inc. provides a range of clinical diagnostic testing products, equipment, and services, including proprietary...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Biomerieux Inc. for a "BIOMERIEUX FULL SERVICE PLAN" with a potential value of $55,853.99. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics and provides a range of proprietary microbiology analyzers, reagents, and test kits to support infectious disease testing and pathogen detection for federal...
This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...
This $104,521.22 firm fixed price delivery order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and services. The contract provides Biomerieux's proprietary microbiology and molecular biology platforms, reagents, and technical support to enable reliable access to critical medical testing capabilities for the VA. This delivery...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The $119,426.38 contract is for "COST PER TEST" services with a completion date of March 31, 2019. As no set-aside was used, this was a full and open competition award. Biomerieux Inc. provides a range of microbiology analyzers, reagents, and molecular diagnostic...
This is a sole source purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biomerieux Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic products. The $123,222.49 firm-fixed-price contract is for the provision of Biomerieux's proprietary microbiology and molecular biology testing platforms, reagents, and support services. This contract supports the VA's infectious disease testing and diagnostic requirements. Biomerieux has multiple...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to Biomerieux Inc. for the provision of DDIMER products. The contract has a potential value of $340,308.92 and a completion date of September 30, 2020. Biomerieux Inc. is a foreign-owned, for-profit manufacturer of goods that has previously provided the VA, Department of Defense, Department of Agriculture, and Department of Health and Human...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This $3,271,440.00 firm-fixed-price definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a global in vitro diagnostics company, for BIONUMERICS SUPPORT services. The contract has a period of performance through July 31, 2025 and does not involve any set-aside designations. Biomerieux Inc., through its Biomerieux, Inc. division, is a leading provider of specialized clinical diagnostic equipment, reagents, and supplies to various federal...